(Q44361930)

2 December 2017

title

Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of ethosuximide by human hepatic microsomal enzymes (English)

1 reference

2 December 2017

1 reference

K Bachmann

1

1 reference

2 December 2017

Y He

series ordinal

2

1 reference

2 December 2017

J G Sarver

series ordinal

3

1 reference

2 December 2017

Ning Peng

series ordinal

4

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

2 December 2017

1 reference

2 December 2017

volume

33

1 reference

2 December 2017

issue

3

1 reference

2 December 2017

page(s)

265-276

1 reference

Effect of enzyme inducing anticonvulsants on ethosuximide pharmacokinetics in epileptic patients

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000061606

Heterogeneity of CYP3A isoforms metabolizing erythromycin and cortisol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000061606

Failure of erythromycin breath test to correlate with midazolam clearance as a probe of cytochrome P4503A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000061606

Detection of anticonvulsants and their metabolites in urine within a "general unknown" analysis procedure using computerized gas chromatography-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000061606

The metabolism of ethosuximide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000061606

First-pass metabolism of midazolam by the human intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000061606

Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000061606

Comparison of urinary 6-beta-cortisol and the erythromycin breath test as measures of hepatic P450IIIA (CYP3A) activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000061606

Noninvasive tests of CYP3A enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000061606

Use of single sample clearance estimates of cytochrome P450 substrates to characterize human hepatic CYP status in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000061606

Absence of correlations among three putative in vivo probes of human cytochrome P4503A activity in young healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000061606

Metabolism of cytochrome P4503A substrates in vivo administered by the same route: lack of correlation between alfentanil clearance and erythromycin breath test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000061606

On the recognition of mammalian microsomal cytochrome P450 substrates and their characteristics: towards the prediction of human p450 substrate specificity and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000061606

Influence of some novel N-substituted azoles and pyridines on rat hepatic CYP3A activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000061606

Comparison of the dapsone recovery ratio and the erythromycin breath test as in vivo probes of CYP3A activity in patients with rheumatoid arthritis receiving cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000061606

10.1080/0049825021000061606

21 January 2018

Identifiers

DOI

1 reference

2 December 2017

1 reference